Nils Anders Haegerstrand
Directeur Général chez ANNEXIN PHARMACEUTICALS AB
Profil
Nils Anders Haegerstrand is currently the Chief Executive Officer at Annexin Pharmaceuticals AB and the Chief Executive Officer at Spatial Transcriptomics AB.
He previously served as the Chief Executive Officer & Head-Research at Newron Sweden AB.
Prior to that, he was the Global Manager at AstraZeneca PLC from 1999 to 2000.
He also held positions as the Manager-Drug Discovery & Development at Karolinska Institutet and Astra Pain Control AB.
Dr. Haegerstrand obtained a doctorate degree from Karolinska Institutet.
Postes actifs de Nils Anders Haegerstrand
| Sociétés | Poste | Début |
|---|---|---|
| ANNEXIN PHARMACEUTICALS AB | Directeur Général | 01/01/2019 |
Spatial Transcriptomics AB
 Spatial Transcriptomics AB Miscellaneous Commercial ServicesCommercial Services Spatial Transcriptomics AB develops technology for RNA sequencing. Its system bridges microscopy and RNA sequencing to generate complete transcriptome data from a single intact tissue sample, and utilizes standard instrumentation for sequencing. The firm's products include ST Tissue Optimization Slide and ST Library Preparation Slide. The company was founded by Jonas Christopher Frisén, Joakim Lundeberg, and Patrik Ståhl and is headquartered in Stockholm, Sweden. | Directeur Général | - |
Anciens postes connus de Nils Anders Haegerstrand
| Sociétés | Poste | Fin |
|---|---|---|
Newron Sweden AB
 Newron Sweden AB Pharmaceuticals: MajorHealth Technology Newron Sweden AB is a biopharmaceutical company engaged in the development of novel therapies for the treatment of disorders of the central nervous systems. The company was founded by Jonas Cristopher Frisen and Ann Marie Janson in 1998 and is headquartered in Stockholm, Sweden. | Directeur Général | 01/06/2017 |
| ASTRAZENECA PLC | Corporate Officer/Principal | 01/01/2000 |
| Astra Pain Control AB | Corporate Officer/Principal | - |
| Karolinska Institutet | Corporate Officer/Principal | - |
Formation de Nils Anders Haegerstrand
| Karolinska Institutet | Doctorate Degree |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| ASTRAZENECA PLC | Health Technology |
| ANNEXIN PHARMACEUTICALS AB | Health Technology |
| Entreprise privées | 3 |
|---|---|
Newron Sweden AB
Newron Sweden AB Pharmaceuticals: MajorHealth Technology Newron Sweden AB is a biopharmaceutical company engaged in the development of novel therapies for the treatment of disorders of the central nervous systems. The company was founded by Jonas Cristopher Frisen and Ann Marie Janson in 1998 and is headquartered in Stockholm, Sweden. | Health Technology |
Spatial Transcriptomics AB
Spatial Transcriptomics AB Miscellaneous Commercial ServicesCommercial Services Spatial Transcriptomics AB develops technology for RNA sequencing. Its system bridges microscopy and RNA sequencing to generate complete transcriptome data from a single intact tissue sample, and utilizes standard instrumentation for sequencing. The firm's products include ST Tissue Optimization Slide and ST Library Preparation Slide. The company was founded by Jonas Christopher Frisén, Joakim Lundeberg, and Patrik Ståhl and is headquartered in Stockholm, Sweden. | Commercial Services |
| Astra Pain Control AB |
